机译:Survivin显性阴性突变体抑制淋巴化转移
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
Department of Radiation Oncology Sichuan Cancer Hospital Chengdu Sichuan China;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
State Key Laboratory of Biotherapy and Cancer Center West China Hospital West China Medical;
Gene therapy; Lymphangiogenesis; Lymphatic metastasis; Mutation; Survivin;
机译:survivin显性阴性突变体对淋巴转移的抑制作用
机译:卵巢癌细胞中前蛋白酶3的表达增加了survivin的转录,可以用显性阴性突变体survivin T34A抵消;联合基因治疗策略
机译:survivin显性阴性突变体增强的肿瘤放射敏感性。
机译:Survivin用EZN-3042抑制犬淋巴瘤治疗:I阶段调查
机译:整联蛋白-细胞因子的串扰和显性负突变体的发展作为潜在的治疗方法
机译:突变的INS基因诱导的青年糖尿病:胰岛素半胱氨酸残基强加对野生型胰岛素运输的负抑制作用。
机译:卵巢癌细胞中的Procaspase 3表达增加了Survivin转录,其可以与显性阴性突变体,Survivin T34a进行抵消;组合基因治疗策略